ZA945930B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA945930B ZA945930B ZA945930A ZA945930A ZA945930B ZA 945930 B ZA945930 B ZA 945930B ZA 945930 A ZA945930 A ZA 945930A ZA 945930 A ZA945930 A ZA 945930A ZA 945930 B ZA945930 B ZA 945930B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939316580A GB9316580D0 (en) | 1993-08-10 | 1993-08-10 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA945930B true ZA945930B (en) | 1995-04-05 |
Family
ID=10740244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA945930A ZA945930B (en) | 1993-08-10 | 1994-08-08 | Pharmaceutical composition |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0720476A1 (en) |
JP (1) | JPH09501421A (en) |
CN (1) | CN1112180C (en) |
AU (1) | AU688789B2 (en) |
CA (1) | CA2169159C (en) |
GB (1) | GB9316580D0 (en) |
TW (1) | TW354256B (en) |
WO (1) | WO1995004528A2 (en) |
ZA (1) | ZA945930B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
ES2171110B1 (en) * | 2000-03-03 | 2003-06-16 | Aplicaciones Farmacodinamicas | PHARMACEUTICAL COMPOSITION BASED ON IBUPROFEN AND PROCEDURE FOR PREPARATION. |
ES2189682B1 (en) * | 2001-12-11 | 2004-04-01 | Laboratorios Del Dr. Esteve, S.A. | DRINKABLE PREPARATION UNDERSTANDING KETOPROPHEN AND ITS EMPLOYMENT IN THE PROCESSING OF PROCESSES PROCESSING WITH FEVER, INFLAMMATION AND / OR PAIN, IN AN ANIMAL COLLECTIVE, SIMULTANEOUSLY. |
CZ2004262A3 (en) * | 2004-02-20 | 2005-06-15 | I. Q. A., A. S. | Stable, taste-acceptable syrups containing ibuprofen and process of their preparation |
US8986735B2 (en) * | 2006-03-16 | 2015-03-24 | Novartis Ag | Solid dosage form containing a taste masked active agent |
KR20080112285A (en) | 2006-03-28 | 2008-12-24 | 자블린 파머슈티칼스 인코포레이티드 | Formulations of low dose diclofenac and beta-cyclodextrin |
CN102448499A (en) * | 2009-04-27 | 2012-05-09 | 药效学应用实验室股份有限公司 | Oral ibuprofen lysinate suspension |
ES2608060T3 (en) * | 2009-04-27 | 2017-04-05 | Laboratorio De Aplicaciones Farmacodinamicas, S.A. | Ibuprofen Lysinate Oral Suspension |
JP5853430B2 (en) * | 2010-06-21 | 2016-02-09 | 大正製薬株式会社 | Oral solution |
CN101987089B (en) * | 2010-11-10 | 2012-07-04 | 天大药业(珠海)有限公司 | Effervescent medicinal preparation |
GB201021267D0 (en) | 2010-12-15 | 2011-01-26 | Reckitt Benckiser Healthcare Int Ltd | Novel pharmaceutical formulation |
US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
JP6282644B2 (en) * | 2012-06-28 | 2018-02-21 | ジヨンソン・アンド・ジヨンソン・コンシユーマー・インコーポレーテツドJohnson & Johnson Consumer Inc. | Racecadotril liquid composition |
RU2015114433A (en) * | 2012-09-18 | 2016-11-10 | МакНЕЙЛ-ППС, ИНК. | ORAL DOSED FORMS WITH SLOW-RELEASE EXTRACTION CONTAINING PARTICLES OF EASY-MELTING DERIVATIVE PROPIONIC ACID |
CN111116794A (en) * | 2019-12-20 | 2020-05-08 | 蚌埠市鑫晟新材料科技有限公司 | Preparation method of neutral polymeric material for papermaking |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5920230A (en) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | Drug containing piruprophen |
DE3440288A1 (en) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | PHARMACEUTICAL PREPARATION WITH A CONTENT OF AT LEAST ONE Mucous-irritating SUBSTANCE OR THE LIKE, PARTICULARLY PROFESSIONALS, AND METHOD FOR THE PRODUCTION THEREOF |
CA1298290C (en) * | 1987-01-09 | 1992-03-31 | Herand M. Markarian | Solution ibuprofen complexes, compositions and processes for preparing the same |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
CH677606A5 (en) * | 1988-07-12 | 1991-06-14 | Aesculapius Pharma Sa | |
DE3838431A1 (en) * | 1988-11-12 | 1990-05-17 | Bayer Ag | IBUPROFEN SHOWER PREPARATIONS |
IT1227626B (en) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION |
US5019663A (en) * | 1989-04-03 | 1991-05-28 | Mobil Oil Corp. | Heat balanced paraffin upgrading with co-fed oxygenate |
JPH02279631A (en) * | 1989-04-18 | 1990-11-15 | Yamanouchi Pharmaceut Co Ltd | Cyclodextrin clathrate for medicine and its production |
CA2009326C (en) * | 1989-05-09 | 1998-01-27 | Lawrence J. Daher | Aqueous granulation solution and a method of tablet granulation |
CA2021548A1 (en) * | 1989-09-01 | 1991-03-02 | Ronald Nash Duvall | Effervescent cold or sinus allergy medicine composition having reduced sodium content |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
DE4027927A1 (en) * | 1990-09-04 | 1992-03-05 | Bayer Ag | SHOWER COMPONENT AND METHOD FOR THEIR PRODUCTION |
DE4038314A1 (en) * | 1990-11-30 | 1992-06-04 | Puetter Medice Chem Pharm | COMPLEXES OF THE ACTIVE ENANTIOMER OF THE IBUPROFEN WITH CYCLODEXTRIN |
JP2579251B2 (en) * | 1991-03-12 | 1997-02-05 | ロシェ・コンシューマー・ヘルス・(ワールドワイド)・リミテッド | Non-effervescent ibuprofen composition |
-
1993
- 1993-08-10 GB GB939316580A patent/GB9316580D0/en active Pending
-
1994
- 1994-07-29 AU AU76099/94A patent/AU688789B2/en not_active Ceased
- 1994-07-29 EP EP94926129A patent/EP0720476A1/en not_active Withdrawn
- 1994-07-29 CA CA002169159A patent/CA2169159C/en not_active Expired - Fee Related
- 1994-07-29 WO PCT/EP1994/002515 patent/WO1995004528A2/en not_active Application Discontinuation
- 1994-07-29 CN CN94193729A patent/CN1112180C/en not_active Expired - Fee Related
- 1994-07-29 JP JP7506202A patent/JPH09501421A/en active Pending
- 1994-08-08 ZA ZA945930A patent/ZA945930B/en unknown
- 1994-08-11 TW TW083107332A patent/TW354256B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW354256B (en) | 1999-03-11 |
EP0720476A1 (en) | 1996-07-10 |
CN1133006A (en) | 1996-10-09 |
AU7609994A (en) | 1995-02-28 |
WO1995004528A2 (en) | 1995-02-16 |
CA2169159A1 (en) | 1995-02-16 |
WO1995004528A3 (en) | 1995-03-16 |
AU688789B2 (en) | 1998-03-19 |
CA2169159C (en) | 2005-01-25 |
JPH09501421A (en) | 1997-02-10 |
GB9316580D0 (en) | 1993-09-29 |
CN1112180C (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9402974D0 (en) | Pharmaceutical composition | |
ZA946262B (en) | Pharmaceutical compositions | |
GB9317610D0 (en) | Pharmaceutical compositions | |
GB9316580D0 (en) | Pharmaceutical composition | |
GB2272375B (en) | Pharmaceutical composition | |
PL314036A1 (en) | Pharmaceutical composition | |
CA2100836A1 (en) | Pharmaceutical Composition | |
GB9317504D0 (en) | Pharmaceutical compositions | |
ZA945752B (en) | Pharmaceutical composition | |
GB9221707D0 (en) | Pharmaceutical composition | |
GB9318880D0 (en) | Pharmaceutical composition | |
HU9401771D0 (en) | Pharmaceutical compositions cintaining ipsapiron | |
ZA947878B (en) | Pharmaceutical compositions | |
GB9318350D0 (en) | Pharmaceutical composition | |
GB9320688D0 (en) | Pharmaceutical composition | |
ZA947913B (en) | Pharmaceutical composition | |
HU9303511D0 (en) | Pharmaceutical composition | |
GB9321671D0 (en) | Pharmaceutical composition | |
GB9314709D0 (en) | Pharmaceutical composition | |
GB9314564D0 (en) | Pharmaceutical composition | |
GB9308849D0 (en) | Pharmaceutical composition | |
ZA935269B (en) | Pharmaceutical composition | |
GB9417021D0 (en) | Pharmaceutical composition | |
HU9303386D0 (en) | Pharmaceutical composition | |
GB9316849D0 (en) | Pharmaceutical compositions |